Source comparison
BPC-157 vs Cortisone Injections — What Actually Works
Fewer than 40% of patients who receive cortisone injections for tendon injuries report sustained improvement beyond six months. And research published in the British Journal of Sports Medicine found that repeated cortisone use can weaken tendon structure by in
This comparison does not assign a generated winner or score.
- Fewer than 40% of patients who receive cortisone injections for tendon injuries report sustained improvement beyond six months. And research published in the British Journal of Sports Medicine found that repeated cortisone use can weaken tendon structure by inhibiting collagen synthesis. BPC-157 differs from cortisone injections fundamentally: cortisone suppresses inflammation temporarily, while BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective gastric protein that actively promotes tissue regeneration through angiogenesis, fibroblast migration, and accelerated collagen deposition.
- Our team has worked with researchers using both modalities extensively. The gap between the two isn't just efficacy. It's mechanism, duration, and long-term tissue integrity.
- How does BPC-157 differ from cortisone injections in treating soft tissue injuries?
- BPC-157 differs from cortisone injections through its regenerative mechanism: it stimulates angiogenesis (new blood vessel formation), accelerates fibroblast migration to the injury site, and increases collagen synthesis. All of which support tissue repair. Cortisone, a corticosteroid, works by suppressing the inflammatory cascade temporarily but does not address the underlying structural damage. BPC-157 targets healing; cortisone targets symptom relief.
- The medical literature frames cortisone as an anti-inflammatory intervention and BPC-157 as a regenerative peptide. Two entirely different therapeutic goals that patients often confuse as interchangeable options. They're not. Cortisone is appropriate when inflammation itself is causing secondary complications (like nerve compression or mobility restriction). BPC-157 is appropriate when the goal is accelerated healing of damaged tissue. Tendons, ligaments, muscle tears, or gastric lining.